A Prospective Hospital-Based Study on the Clinico-Etiological Profile of the First Episode of a Seizure in Children

Prashanthi M1, Sai Chandar Dudipala1,2, Roop Shankar3

  • 1Pediatrics, Prathima Institute of Medical Sciences, Karimnagar, IND.

Cureus
|December 14, 2022
PubMed

Insights

This study found generalized-onset seizures were most common in children experiencing their first seizure. Febrile seizures were the leading cause, highlighting the importance of thorough clinical evaluation for identifying seizure etiology in pediatric patients.

Area of Science:

  • Pediatric Neurology
  • Epileptology
  • Clinical Neuroscience

Background:

  • First-episode seizures in children present a significant clinical challenge.
  • Understanding the clinico-etiological profile is crucial for diagnosis and management.
  • Pediatric seizure classification requires age-specific considerations.

Purpose of the Study:

  • To investigate the clinical and etiological characteristics of first-episode seizures in children.
  • To categorize seizure types based on age groups.
  • To identify the primary causes of initial seizures in pediatric populations.

Main Methods:

  • A prospective observational study was conducted over two years.
  • Included children aged one month to 12 years with a first seizure episode.
  • Data collected included demographics, clinical history, EEG, and neuroimaging, classified per ILAE 2017 guidelines.

Main Results:

  • Generalized-onset seizures (50%) were more frequent than focal-onset seizures (43.6%).
  • Febrile seizures (41.9%) were the most common etiology, predominantly in children aged 1-4 years.
  • Abnormal EEG (76%) and neuroimaging (60%) findings were frequent, with epilepsy syndromes and CNS infections as other key etiologies.

Conclusions:

  • Detailed clinical evaluation and investigations are vital for determining seizure etiology in children.
  • Generalized-onset seizures and febrile seizures represent significant proportions of first-episode seizures.
  • Identifying specific etiologies like epilepsy syndromes, CNS infections, and metabolic disorders is achievable in most pediatric cases.

Related Concept Videos

Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
524
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
241
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
399
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
242